MedPath

Prospective observational study of cancer-cachexia and its effect on chemotherapy in patients with previously-untreated advanced non-small cell lung cancer (NEJ050A)

Not Applicable
Conditions
on-small cell lung cancer
Registration Number
JPRN-UMIN000041813
Lead Sponsor
orth East Japan Study Group (NEJSG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
186
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Current use of corticosteroids. (2) Subjects scheduled to receive treatment, but don't fit into cohorts 1, 2, or 3. (3) Subjects who are unable to accurately complete the QOL questionnaire. (4) Subjects who are judged by the principal or sub-investigator to be unsuitable for inclusion in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Transition of FAACT (A/CS) during chemotherapy
Secondary Outcome Measures
NameTimeMethod
Questionnaire for eating-related distress among patients with advanced cancer (QERD), Care Notebook, FACT-G, anchor questionnaire, ECOG PS, KPS, body weight, objective response rate, disease control rate, progression-free survival, overall survival, adverse events, minimally important difference in QERD, validation of QERD, proportion of cachexia
© Copyright 2025. All Rights Reserved by MedPath